Global Recombinant Proteins Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	178 Pages	TechNavio	July, 2024	INF19033695

Best Price Guarantee
Price	from $2,500
Length	178 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033695

Global Recombinant Proteins Market 2024-2028

The recombinant proteins market is forecasted to grow by USD 778.5 mn during 2023-2028, accelerating at a CAGR of 10.23% during the forecast period. The report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in chronic diseases, rising inclination toward biologics and biosimilars, and technological advancements in production of recombinant proteins.

Technavio's recombinant proteins market is segmented as below:

By Application

Biotechnology research
Drug discovery and development
Biopharmaceutical production
Others

By End-user

Pharma and biotechnology companies
Academic and research institutes
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in collaborations and strategic alliances by vendors as one of the prime reasons driving the recombinant proteins market growth during the next few years. Also, increased expenditure on r and d and growing opportunities from emerging economies will lead to sizable demand in the market.

The report on the recombinant proteins market covers the following areas:

Recombinant proteins market sizing
Recombinant proteins market forecast
Recombinant proteins market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading recombinant proteins market vendors that include Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Techne Corp., Bio Rad Laboratories Inc., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the recombinant proteins market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Recombinant Proteins Market 2018 - 2022; Historic Market Size - Data Table on Global Recombinant Proteins Market 2018 - 2022 ($ million); 4.2 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 6.3 Biotechnology research - Market size and forecast 2023-2028; Chart on Biotechnology research - Market size and forecast 2023-2028 ($ million); Data Table on Biotechnology research - Market size and forecast 2023-2028 ($ million); Chart on Biotechnology research - Year-over-year growth 2023-2028 (%); Data Table on Biotechnology research - Year-over-year growth 2023-2028 (%); 6.4 Drug discovery and development - Market size and forecast 2023-2028; Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%); Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%); 6.5 Biopharmaceutical production - Market size and forecast 2023-2028; Chart on Biopharmaceutical production - Market size and forecast 2023-2028 ($ million); Data Table on Biopharmaceutical production - Market size and forecast 2023-2028 ($ million); Chart on Biopharmaceutical production - Year-over-year growth 2023-2028 (%); Data Table on Biopharmaceutical production - Year-over-year growth 2023-2028 (%); 6.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 7.3 Pharma and biotechnology companies - Market size and forecast 2023-2028; Chart on Pharma and biotechnology companies - Market size and forecast 2023-2028 ($ million); Data Table on Pharma and biotechnology companies - Market size and forecast 2023-2028 ($ million); Chart on Pharma and biotechnology companies - Year-over-year growth 2023-2028 (%); Data Table on Pharma and biotechnology companies - Year-over-year growth 2023-2028 (%); 7.4 Academic and research institutes - Market size and forecast 2023-2028; Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Italy - Market size and forecast 2023-2028; Chart on Italy - Market size and forecast 2023-2028 ($ million); Data Table on Italy - Market size and forecast 2023-2028 ($ million); Chart on Italy - Year-over-year growth 2023-2028 (%); Data Table on Italy - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abcam plc; Abcam plc - Overview; Abcam plc - Product / Service; Abcam plc - Key news; Abcam plc - Key offerings; 12.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.5 Aviva Systems Biology Corp.; Aviva Systems Biology Corp. - Overview; Aviva Systems Biology Corp. - Product / Service; Aviva Systems Biology Corp. - Key offerings; 12.6 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; 12.7 BPS Bioscience Inc.; BPS Bioscience Inc. - Overview; BPS Bioscience Inc. - Product / Service; BPS Bioscience Inc. - Key offerings; 12.8 Enzo Biochem Inc.; Enzo Biochem Inc. - Overview; Enzo Biochem Inc. - Product / Service; Enzo Biochem Inc. - Key news; Enzo Biochem Inc. - Key offerings; 12.9 GenScript Biotech Corp.; GenScript Biotech Corp. - Overview; GenScript Biotech Corp. - Business segments; GenScript Biotech Corp. - Key news; GenScript Biotech Corp. - Key offerings; GenScript Biotech Corp. - Segment focus; 12.10 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.11 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.12 Novo Nordisk AS; Novo Nordisk AS - Overview; Novo Nordisk AS - Business segments; Novo Nordisk AS - Key news; Novo Nordisk AS - Key offerings; Novo Nordisk AS - Segment focus; 12.13 Prospec Tany Technogene Ltd.; Prospec Tany Technogene Ltd. - Overview; Prospec Tany Technogene Ltd. - Product / Service; Prospec Tany Technogene Ltd. - Key offerings; 12.14 Proteintech Group Inc.; Proteintech Group Inc. - Overview; Proteintech Group Inc. - Product / Service; Proteintech Group Inc. - Key offerings; 12.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.16 Sino Biological Inc.; Sino Biological Inc. - Overview; Sino Biological Inc. - Product / Service; Sino Biological Inc. - Key offerings; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Recombinant Proteins Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Application - Market share 2023-2028 (%); Exhibits33: Data Table on Application - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Application; Exhibits35: Data Table on Comparison by Application; Exhibits36: Chart on Biotechnology research - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Biotechnology research - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Biotechnology research - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Biotechnology research - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Biopharmaceutical production - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Biopharmaceutical production - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Biopharmaceutical production - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Biopharmaceutical production - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits52: Market opportunity by Application ($ million); Exhibits53: Data Table on Market opportunity by Application ($ million); Exhibits54: Chart on End-user - Market share 2023-2028 (%); Exhibits55: Data Table on End-user - Market share 2023-2028 (%); Exhibits56: Chart on Comparison by End-user; Exhibits57: Data Table on Comparison by End-user; Exhibits58: Chart on Pharma and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Pharma and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Pharma and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Pharma and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by End-user ($ million); Exhibits71: Data Table on Market opportunity by End-user ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Italy - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Italy - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Italy - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Italy - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Abcam plc - Overview; Exhibits122: Abcam plc - Product / Service; Exhibits123: Abcam plc - Key news; Exhibits124: Abcam plc - Key offerings; Exhibits125: Amgen Inc. - Overview; Exhibits126: Amgen Inc. - Product / Service; Exhibits127: Amgen Inc. - Key news; Exhibits128: Amgen Inc. - Key offerings; Exhibits129: Aviva Systems Biology Corp. - Overview; Exhibits130: Aviva Systems Biology Corp. - Product / Service; Exhibits131: Aviva Systems Biology Corp. - Key offerings; Exhibits132: Bio Rad Laboratories Inc. - Overview; Exhibits133: Bio Rad Laboratories Inc. - Business segments; Exhibits134: Bio Rad Laboratories Inc. - Key news; Exhibits135: Bio Rad Laboratories Inc. - Key offerings; Exhibits136: Bio Rad Laboratories Inc. - Segment focus; Exhibits137: BPS Bioscience Inc. - Overview; Exhibits138: BPS Bioscience Inc. - Product / Service; Exhibits139: BPS Bioscience Inc. - Key offerings; Exhibits140: Enzo Biochem Inc. - Overview; Exhibits141: Enzo Biochem Inc. - Product / Service; Exhibits142: Enzo Biochem Inc. - Key news; Exhibits143: Enzo Biochem Inc. - Key offerings; Exhibits144: GenScript Biotech Corp. - Overview; Exhibits145: GenScript Biotech Corp. - Business segments; Exhibits146: GenScript Biotech Corp. - Key news; Exhibits147: GenScript Biotech Corp. - Key offerings; Exhibits148: GenScript Biotech Corp. - Segment focus; Exhibits149: Merck KGaA - Overview; Exhibits150: Merck KGaA - Business segments; Exhibits151: Merck KGaA - Key news; Exhibits152: Merck KGaA - Key offerings; Exhibits153: Merck KGaA - Segment focus; Exhibits154: Novartis AG - Overview; Exhibits155: Novartis AG - Business segments; Exhibits156: Novartis AG - Key news; Exhibits157: Novartis AG - Key offerings; Exhibits158: Novartis AG - Segment focus; Exhibits159: Novo Nordisk AS - Overview; Exhibits160: Novo Nordisk AS - Business segments; Exhibits161: Novo Nordisk AS - Key news; Exhibits162: Novo Nordisk AS - Key offerings; Exhibits163: Novo Nordisk AS - Segment focus; Exhibits164: Prospec Tany Technogene Ltd. - Overview; Exhibits165: Prospec Tany Technogene Ltd. - Product / Service; Exhibits166: Prospec Tany Technogene Ltd. - Key offerings; Exhibits167: Proteintech Group Inc. - Overview; Exhibits168: Proteintech Group Inc. - Product / Service; Exhibits169: Proteintech Group Inc. - Key offerings; Exhibits170: Sanofi SA - Overview; Exhibits171: Sanofi SA - Business segments; Exhibits172: Sanofi SA - Key news; Exhibits173: Sanofi SA - Key offerings; Exhibits174: Sanofi SA - Segment focus; Exhibits175: Sino Biological Inc. - Overview; Exhibits176: Sino Biological Inc. - Product / Service; Exhibits177: Sino Biological Inc. - Key offerings; Exhibits178: Thermo Fisher Scientific Inc. - Overview; Exhibits179: Thermo Fisher Scientific Inc. - Business segments; Exhibits180: Thermo Fisher Scientific Inc. - Key news; Exhibits181: Thermo Fisher Scientific Inc. - Key offerings; Exhibits182: Thermo Fisher Scientific Inc. - Segment focus; Exhibits183: Inclusions checklist; Exhibits184: Exclusions checklist; Exhibits185: Currency conversion rates for US$; Exhibits186: Research methodology; Exhibits187: Information sources; Exhibits188: Data validation; Exhibits189: Validation techniques employed for market sizing; Exhibits190: Data synthesis; Exhibits191: 360 degree market analysis; Exhibits192: List of abbreviations